Principal Securities »

Ishares Tr genomics immun shares owned by Principal Securities

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Principal Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $60k 2.6k 23.01

More positions owned by Principal Securities

Ishares Tr Core Us Aggbd Et (AGG)
Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Access Us Agrat (GCOR)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Rus 1000 Etf (IWB)
Principal Exchange Traded Prnc Invt Grad (IG)
Amazon (AMZN)
Apple (AAPL)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Principal Securities

Top funds holding Ishares Tr genomics immun

Jane Street
Wharton Business Group
Bank of America Corporation
UBS Group
Royal Bank of Canada
Bsc Private Wealth Management
Commonwealth Equity Services
Advisor Group Holdings
Cora Capital Advisors
Citadel Advisors
Visionary Wealth Advisors
Raymond James Financial Services Advisors
Branch Banking & Trust Company
TCG Advisory Services
PFG Investments

View all funds holding Ishares Tr genomics immun